- Claude Bernard -

Select Publications in Recent Years:

​

1. Perron J, Ko JH, “Brain Age Estimation: Premise, Promise and Problems,” Neural Regeneration Research, vol. 20(8), pp. 2313-2314, August 2025

2. Beheshti, Ko JH, “Predicting the Occurrence of Mild Cognitive Impairment in Parkinson’s Disease Using Structural MRI data,” Frontiers in Neuroscience, vol. 18, pp. 1375395, April 2024.

3. Wood S, Booth S, Ko JH, “Functional Connectivity Alteration in PTSD Patients with Suicidal Ideation,” Brain Research Bulletin, vol. 209, pp. 110905, April 2024.

4. Booth S, Ko JH, “Radionuclide imaging of the neuroanatomical and neurochemical substrate of cognitive decline in Parkinson’s Disease,” Nuclear Medicine and Molecular Imaging, vol. 58(4), pp. 213-226, February 2024.

5. Beheshti I, Booth S, Ko JH, “Differences in brain aging between sexes in Parkinson's disease,” npj Parkinson’s Disease, vol. 10, pp. 10, February 2024.

6. Perron J, Scramstad C, Ko JH, “Analysis of Costs for Imaging-Assisted Pharmaceutical Intervention in Alzheimer’s Disease with Lecanemab: Snapshot of the First 3 Years,” Journal of Alzheimer’s Disease, vol. 96(3), pp. 1305-1315, November 2023.

7. Gupta V, Booth S, Ko JH, “Hypermetabolic Cerebellar Connectome in Alzheimer’s Disease,” Brain Connectivity, vol. 13(6), pp. 356-366, August 2023.

8. He M, Kolesar TA, Goertzen AL, Ng MC, Ko JH, “Do Epilepsy Patients with Cognitive Impairment have Alzheimer’s Disease-like Brain Metabolism?” Biomedicines, vol. 11(3), pp. 1108, April 2023.

9. Ng MC, El-Alawi H, Toutant D, Choi EH, Wright N, Khanam M, Paunovic B, Ko JH, “A pilot study of high-definition transcranial direct current stimulation in refractory status epilepticus: the SURESTEP trial,” Neurotherapeutics, vol. 20(1), pp. 181-194, January 2023.

10. Perron J, Ko JH, “Review of Quantitative Methods for the Detection of Alzheimer’s Disease with Positron Emission Tomography,” Applied Sciences, vol. 12(22), pp. 11463, November 2022

11. Booth S, Park KW, Lee CS, Ko JH, “Predicting cognitive decline in Parkinson's disease using FDG-PET based supervised learning,” Journal of Clinical Investigation, vol. 132(20), pp. e157074, October 2022.

12. Beheshti I, Geddert N, Perron J, Gupta V, Albensi BC, Ko JH, “Monitoring Alzheimer’s Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-based FDG-PET Classification Methods,” Journal of Alzheimer’s Disease, vol. 89(4), pp. 1493-1502, October 2022.

13. Wright N, Patel R, Chaulk S, Alcolado G, Podnar D, Mota N, Monson CM, Girard TA, Ko JH, “Novel analysis identifying functional connectivity patterns associated with posttraumatic stress disorder,” Chronic Stress, vol. 6, pp. 24705470221092428, April 2022.

14. Lau A, Beheshti I, Modirrousta M, Kolesar TA, Goertzen AL, Ko JH, “Alzheimer’s disease-related metabolic pattern in diverse forms of neurodegenerative diseases,” Diagnostics, vol. 11(11), pp. 2023, November 2021.

15. Szturm T, Kolesar TA, Mahana B, Goertzen A, Hobson DE, Marotta JJ, Strafella AP, Ko JH, “Changes in Metabolic Activity and Gait Function by Dual-Task Cognitive Game-Based Treadmill System in Parkinson's Disease: Protocol and Preliminary Data of a Randomized Controlled Trial,” Frontiers in Aging Neuroscience, vol. 13, pp. 680270, June 2021.

16. Booth S, Ramadan A, Zhang D, Lu L, Kirouac GJ, Jackson MF, Anderson C, Ko JH, “The Vasomotor Response to Dopamine is altered in the rat model of L-DOPA Induced Dyskinesia,” Movement Disorders, vol. 36(4), pp. 938-947, April 2021.

17. Szturm T, Beheshti I, Mahana B, Hobson DE, Goertzen A, Ko JH, “Imaging glucose metabolism during dual-task walking in patients with Parkinson’s disease,” Journal of Neuroimaging, vol. 31(2), pp. 356-362, March 2021.

18. Beheshti I, Ko JH, "Modulating Brain Networks Associated with Cognitive Deficits in Parkinson's Disease," Molecular Medicine, vol. 27, 24, March 2021​

 

For a complete list of publication, please visit:

​

[PubMed link], [Scopus link], [ORCID link]